Assistant Professor, Medicine, Hematology Oncology Division; Feinberg School of Medicine
View Publications Listing
The focus of Dr. Petrich's research is on the use of novel drugs and drug combinations for the treatment of lymphomas. His laboratory research has focused on exploring epigenomic differences that account for differences is response of lymphoma cells to chemotherapy. His research has focused specifically on the Akt/mTOR pathway, with the hopes that more effective targeting of molecules in this pathway may lead to improved outcome in certain types of non-Hodgkin lymphoma. He is the local principal investigator of a number of clinical trials, and is actively recruiting patients to the many active trials available here at Northwestern.